Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Keyomarsi

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Cancer Research|February 15, 1997
Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashionJ Gray-Bablin, S Rao, K Keyomarsi
Methods in Enzymology|January 1, 1986
Preparation of (6S)-5-formyltetrahydrofolate labeled at high specific activity with 14C and 3HR G Moran, K Keyomarsi, P D Colman
Nature Medicine|March 1, 1996
Cyclin E -- a better prognostic marker for breast cancer than cyclin D?Q P Dou, A B Pardee, K Keyomarsi
Oncogene|June 30, 2009
Post-translational modification and stability of low molecular weight cyclin EB B Mull, J Cox, T Bui, et al.
Oncogene|November 12, 1998
Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53S Rao, M Lowe, T W Herliczek, et al.
Oncogene|September 7, 1995
Deregulation of cyclin E in breast cancerK Keyomarsi, D Conte, W Toyofuku, et al.
The Journal of Biological Chemistry|July 15, 1993
The thymidylate synthase inhibitor, ICI D1694, overcomes translational detainment of the enzymeK Keyomarsi, J Samet, G Molnar, et al.
The Journal of Biological Chemistry|October 5, 1992
Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogeneT Motokura, K Keyomarsi, H M Kronenberg, et al.
Cancer Research|July 1, 1991
Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatinK Keyomarsi, L Sandoval, V Band, et al.
Clinical Chemistry|January 1, 1987
Drugs in blood donorsV Mahnovski, M H Cheng, A I Lipsey, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Cancer Research|February 15, 1997
Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashionJ Gray-Bablin, S Rao, K Keyomarsi
Methods in Enzymology|January 1, 1986
Preparation of (6S)-5-formyltetrahydrofolate labeled at high specific activity with 14C and 3HR G Moran, K Keyomarsi, P D Colman
Nature Medicine|March 1, 1996
Cyclin E -- a better prognostic marker for breast cancer than cyclin D?Q P Dou, A B Pardee, K Keyomarsi
Oncogene|June 30, 2009
Post-translational modification and stability of low molecular weight cyclin EB B Mull, J Cox, T Bui, et al.
Oncogene|November 12, 1998
Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53S Rao, M Lowe, T W Herliczek, et al.
Oncogene|September 7, 1995
Deregulation of cyclin E in breast cancerK Keyomarsi, D Conte, W Toyofuku, et al.
The Journal of Biological Chemistry|July 15, 1993
The thymidylate synthase inhibitor, ICI D1694, overcomes translational detainment of the enzymeK Keyomarsi, J Samet, G Molnar, et al.
The Journal of Biological Chemistry|October 5, 1992
Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogeneT Motokura, K Keyomarsi, H M Kronenberg, et al.
Cancer Research|July 1, 1991
Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatinK Keyomarsi, L Sandoval, V Band, et al.
Clinical Chemistry|January 1, 1987
Drugs in blood donorsV Mahnovski, M H Cheng, A I Lipsey, et al.
Pageof 5